JPRN-UMIN000050583招募中4 期
Study for the efficacy and safety of oral semaglutide in subjects with type 2 diabetes -retrospective observation trial - Study for the usefulness and safety of oral semaglutide
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Subjects for whom administration of oral semaglutide is contraindicated in the package insert (a history of hypersensitivity to the components of this drug, hyperglycemic emergencies such as diabetic ketoacidosis, severe infections) 2) Subjects who are inadequate to enter this study due to the other reasons by physician's judgments
研究者
相似试验
招募中
1 期
PIONEER TEENS. A research study to compare a new medicine oral semaglutide to a dummy medicine in children and teenagers with type 2 diabetes.Type 2 diabetesCTIS2023-506923-27-00ovo Nordisk A/S127
进行中（未招募）
1 期
Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation versus Sitagliptin in Subjects with Type 2 Diabetes MellitusMedDRA version: 20.1 Level: LLT Classification code 10045242 Term: Type II diabetes mellitus System Organ Class: 100000004861Diabetes Mellitus, Type 2EUCTR2015-005593-38-ATovo Nordisk A/S500
进行中（未招募）
1 期
Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation versus Sitagliptin in Subjects with Type 2 Diabetes MellitusDiabetes Mellitus, Type 2EUCTR2015-005593-38-BEovo Nordisk A/S500
Unknown
3 期
This trial is to see Efficacy and long-term safety of oral semaglutide versus sitagliptin in subjects with type 2 diabetesCTRI/2018/02/011670ovo Nordisk AS
进行中（未招募）
1 期
Efficacy and long-term safety of oral semaglutide versus sitagliptin in subjects with type 2 diabetesMedDRA version: 20.1 Level: LLT Classification code 10045242 Term: Type II diabetes mellitus System Organ Class: 100000004861Diabetes Mellitus, Type 2EUCTR2015-001351-71-GBovo Nordisk A/S1,863